MedPath

Pioneer Surgical Technology, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

22

Active:0
Completed:13

Trial Phases

4 Phases

Phase 2:1
Phase 3:3
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Not Applicable
11 (68.8%)
Phase 3
3 (18.8%)
Phase 2
1 (6.3%)
Phase 4
1 (6.3%)

Post Market Study of Tutopatch In Craniotomy

Not yet recruiting
Conditions
Craniotomy
First Posted Date
2025-08-12
Last Posted Date
2025-08-17
Lead Sponsor
RTI Surgical
Target Recruit Count
75
Registration Number
NCT07118020

Acellular Dermal Matrix Investigation in Breast Reconstruction

Not Applicable
Recruiting
Conditions
Breast Reconstruction
First Posted Date
2024-06-13
Last Posted Date
2025-08-06
Lead Sponsor
RTI Surgical
Target Recruit Count
467
Registration Number
NCT06456554
Locations
🇺🇸

Mercy Hospital, Saint Louis, Missouri, United States

🇺🇸

University of Colorado, Aurora, Colorado, United States

🇺🇸

Washington University, Saint Louis, Missouri, United States

and more 4 locations

A Prospective Study of Fortiva in Hernia Repair

Conditions
Ventral Hernia
Abdominal Wall Reconstruction
Incisional Hernia
First Posted Date
2023-10-26
Last Posted Date
2025-07-25
Lead Sponsor
RTI Surgical
Target Recruit Count
120
Registration Number
NCT06101979
Locations
🇬🇧

James Paget University Hospital, Great Yarmouth, United Kingdom

Streamline Occipito-Cervico-Thoracic System Post-Market Clinical Follow-up

Completed
Conditions
Spinal Stenosis Occipito-Atlanto-Axial
Spinal Stenosis Cervical
Spinal Stenosis Cervicothoracic Region
Spinal Disease
Spinal Instability
First Posted Date
2019-11-21
Last Posted Date
2020-10-27
Lead Sponsor
RTI Surgical
Target Recruit Count
60
Registration Number
NCT04171544
Locations
🇺🇸

Las Vegas Neurosurgical Institute, Las Vegas, Nevada, United States

🇺🇸

Spine Nevada, Reno, Nevada, United States

A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis

Not Applicable
Completed
Conditions
Mammoplasty
First Posted Date
2018-11-16
Last Posted Date
2024-05-02
Lead Sponsor
RTI Surgical
Target Recruit Count
87
Registration Number
NCT03744013
Locations
🇩🇪

Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany

🇩🇪

Frankfurt University Hospital, Frankfurt am Main, Germany

🇩🇪

University Hospital Technical University, Munich, München, Germany

and more 3 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

RTI Surgical Initiates ADMIRE Study for Cortiva Allograft Dermis in Breast Reconstruction

RTI Surgical has enrolled the first patient in the ADMIRE study to evaluate Cortiva Allograft Dermis for implant-based breast reconstruction.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.